semaglutide side effect lawsuit in louisiana Pros and cons of GLP-1 shots over pills? Doc weighs louisiana semaglutide gastroparesis lawsuit Ozempic,

To view or add a comment, sign in Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology This article highlights a critical point for improving cardiovascular prevention strategies: Because clinicians will not treat what they do not measure, universal screening of hsCRP in both primary and secondary prevention patients, in combination with cholesterol, represents a major clinical opportunity and is therefore recommended

For example, Novo Nordisk, the manufacturer of Ozempic, offers a patient assistance program for uninsured or Medicare patients who qualify and are prescribed Ozempic for type 2 diabetes

Clinical and translational gastroenterology

References Matteucci E, Giampietro O